Arkolith/Insider Trading/MLTX/Form 4

Bodenstedt Matthias

Chief Financial OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Dec 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.9M
Net Open-Market Flow
-$5.9M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2023Sell(S)5K$58.34$307K521K
Dec 19, 2023Sell(S)95K$59.22$5.6M526K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-097671) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML